Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Arena's Financing Deal with Azimuth Is a Healthy Move
- Mark Cifra submits: Secondaries and convertibles are pretty common stuff to most biotech investors. That is why when I first read the news that Arena Pharmaceuticals ARNA signed an equity financing commitment deal for 50 million dollars, I figured it was the same old biotech secondary. Until I caught the...
- External links 2009-03-25
- Buying ViroPharma Ahead of June 3rd FDA Decision
- Mark Cifra submits: Is it just me or does it seem like the good old days of biotech are back? With monster moves from Dendreon DNDN and Map Pharma MAPP based on positive phase 3 data, buyouts of IDM Pharma IDMI by Takeda and Cougar Biotech CGRB by [[JNJ]] and...
- External links 2009-05-28
- << Previous
- page 1 of 1
- Next >>
